Published in Arch Dis Child on July 01, 1998
Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis (2004) 1.89
Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol (2008) 1.36
Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease. J Inherit Metab Dis (2014) 0.99
Approach to neurometabolic diseases from a pediatric neurological point of view. Iran J Child Neurol (2015) 0.76
Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child (1999) 0.75
A Diagnostic Algorithm for Mitochondrial Disorders in Estonian Children. Mol Syndromol (2012) 0.75
Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child (1999) 0.75
Myopathology of Adult and Paediatric Mitochondrial Diseases. J Clin Med (2017) 0.75
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature (1988) 7.65
Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell (1990) 6.80
A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet (1990) 4.96
An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature (1989) 3.75
Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet (1989) 2.98
The clinical features of mitochondrial myopathy. Brain (1986) 2.95
Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet (1992) 2.41
Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet (1991) 2.36
Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol (1977) 1.90
Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol (1989) 1.88
A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol (1993) 1.70
The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol (1993) 1.53
Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain (1995) 1.42
Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann Neurol (1990) 1.28
Mitochondrial tRNA(thr) mutation in fatal infantile respiratory enzyme deficiency. Biochem Biophys Res Commun (1991) 1.24
Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology (1992) 1.18
MR of Leigh's disease (subacute necrotizing encephalomyelopathy). AJNR Am J Neuroradiol (1987) 1.08
Maternally inherited Leigh syndrome. J Pediatr (1993) 1.05
Subacute necrotizing encephalomyelopathy (Leigh's disease): a consideration of clinical features and etiology. Dev Med Child Neurol (1972) 1.03
Mitochondrial DNA mutation underlying Leigh's syndrome: clinical, pathological, biochemical, and genetic studies of a patient presenting with progressive myoclonic epilepsy. J Neurol Sci (1994) 0.94
Pearson's syndrome without marrow involvement. Arch Dis Child (1997) 0.92
Progression from MERRF to MELAS phenotype in a patient with combined respiratory complex I and IV deficiencies. J Neurol Sci (1988) 0.90
Clinical and morphologic features of a myopathy associated with a point mutation in the mitochondrial tRNA(Pro) gene. Neurology (1994) 0.88
Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patients. Neurology (1991) 0.87
Leigh disease (subacute necrotizing encephalomyelopathy): CT and MR in five cases. J Comput Assist Tomogr (1988) 0.85
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (1991) 9.89
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature (1988) 7.65
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain (1981) 5.19
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet (1990) 4.96
The clinical features of hereditary motor and sensory neuropathy types I and II. Brain (1980) 4.79
Classification of the hereditary ataxias and paraplegias. Lancet (1983) 4.44
Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet (1992) 3.55
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy. J Med Genet (1989) 3.25
Hereditary "pure" spastic paraplegia: a clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatry (1981) 2.95
The clinical features of mitochondrial myopathy. Brain (1986) 2.95
The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain (1995) 2.94
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56
PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49
Recommendations for the management of galactosaemia. UK Galactosaemia Steering Group. Arch Dis Child (1999) 2.39
A study of hereditary essential tremor. Brain (1994) 2.37
Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet (1980) 2.36
Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet (1991) 2.36
Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess (1997) 2.20
Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet (1992) 2.18
Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy. Lancet (1994) 2.17
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet (1997) 2.16
Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics (1996) 2.08
Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet (1996) 2.03
Absence of linkage of hereditary motor and sensory neuropathy type I to chromosome 1 markers. Genomics (1989) 2.00
Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med (1985) 1.99
Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet (1989) 1.97
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol (1989) 1.88
Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child (1990) 1.86
A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain (1999) 1.84
Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology (2005) 1.77
Pancreatitis in patients with organic acidemias. J Pediatr (1994) 1.73
Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations. J Med Genet (1995) 1.73
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet (2001) 1.72
Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J (1977) 1.71
Cardiomyopathy in propionic acidaemia. Eur J Pediatr (1993) 1.70
A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69
Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain (1991) 1.67
Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? Hum Mol Genet (1997) 1.67
Genetic association studies: genes in search of diseases. Neurology (2001) 1.65
Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. Brain (1997) 1.65
The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology (2004) 1.63
The phenotypic manifestations of chromosome 17p11.2 duplication. Brain (1997) 1.63
Understanding the molecular causes of Parkinson's disease. Trends Mol Med (2006) 1.62
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
Intrafamilial correlation in Friedreich's ataxia. Clin Genet (1981) 1.62
Degenerative cerebellar ataxia and focal dystonia. Mov Disord (1988) 1.58
The British Isles survey of multiple sclerosis in twins. Neurology (1994) 1.57
Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Ann Neurol (1982) 1.56
Tau gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Neurosurg Psychiatry (2004) 1.56
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Vitamin E and the nervous system. Crit Rev Neurobiol (1987) 1.55
Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia. Lancet (1984) 1.55
The early detection and management of inborn errors presenting acutely in the neonatal period. Eur J Pediatr (1985) 1.53
Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain (1995) 1.53
Regional variations in medium-chain acyl-CoA dehydrogenase deficiency. Lancet (1995) 1.52
Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion. J Inherit Metab Dis (2002) 1.51
Contribution of aminoacid catabolism to propionate production in methylmalonic acidaemia. Lancet (1989) 1.50
Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet (1991) 1.50
Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood. Arch Dis Child (1992) 1.49
PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology (2004) 1.49
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol (2000) 1.47
Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46
Peroneal muscular atrophy with pyramidal features. J Neurol Neurosurg Psychiatry (1984) 1.45
A case-control study of idiopathic torsion dystonia. Mov Disord (1991) 1.45
Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child (1998) 1.45
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain (2001) 1.44
Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ (2008) 1.44
Cerebroretinal microangiopathy with calcifications and cysts (CRMCC). Am J Med Genet A (2008) 1.44
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Hereditary distal spinal muscular atrophy. A report on 34 cases and a review of the literature. J Neurol Sci (1980) 1.41
Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr (2000) 1.41
Neurological outcome of methylmalonic acidaemia. Arch Dis Child (1998) 1.40
Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest (1996) 1.40
The heart disease of Friedreich's ataxia: a clinical and electrocardiographic study of 115 patients, with an analysis of serial electrocardiographic changes in 30 cases. Q J Med (1983) 1.39
Biotinidase deficiency: early neurological presentation. Dev Med Child Neurol (1994) 1.39
A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype. J Pediatr (1998) 1.39
Hypoglycaemia complicating feeding regimens for glycogen-storage disease. Lancet (1978) 1.39
Serum vitamin E concentrations in degenerative ataxias. J Neurol Neurosurg Psychiatry (1989) 1.38
How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency? J Inherit Metab Dis (2004) 1.38
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet (1996) 1.38
Autosomal recessive forms of hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry (1980) 1.36
Neurological implications of urea cycle disorders. J Inherit Metab Dis (2007) 1.36
Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol (1993) 1.35
Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis (2008) 1.34
A genetic study of idiopathic focal dystonias. Ann Neurol (1991) 1.33
Multiple sclerosis in the Cambridge health district of east Anglia. J Neurol Neurosurg Psychiatry (1992) 1.33
Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37. Am J Hum Genet (1995) 1.32
Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis. Arch Dis Child (1999) 1.32
Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids. J Clin Invest (1987) 1.32